WALTER WARRINER: Open Payments
NPI 1215911979 · RANDOLPH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 42 payments from 12 companies in 2025. Trend: 2023 $519 · 2024 $794 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $365 |
| Alkermes, Inc. | 6 | $141 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Lundbeck LLC | 3 | $74 |
| ABBVIE INC. | 3 | $69 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Braeburn Inc. | 2 | $39 |
Products named: REXULTI, ARISTADA, COBENFY, VRAYLAR, ABILIFY ASIMTUFII, INGREZZA, TRINTELLIX, Qelbree.
Industry payments across NY — which companies pay providers there.
